✦ LIBER ✦

Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma

✍ Scribed by Ho-Jin Shin; Joo Seop Chung; Moo-Kon Song; Seon-Kyeong Kim; Sangmin Choe; Goon-Jae Cho

Book ID: 113028047
Publisher: Springer
Year: 2012
Tongue: English
Weight: 423 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1814-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab and CHOP for elderly patients

Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma

✍ Carol S. Portlock 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 116 KB

CHOP Chemotherapy plus Rituximab Compare

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

✍ Coiffier, Bertrand; Lepage, Eric; Brière, Josette; Herbrecht, Raoul; Tilly, Herv 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 116 KB

CHOP Chemotherapy plus Rituximab Compare

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

✍ Coiffier, Bertrand; Lepage, Eric; Brière, Josette; Herbrecht, Raoul; Tilly, Herv 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 116 KB

## Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conduct

Rituximab in combination with CHOP chemo

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

✍ J. M. Li; L. Wang; Y. Shen; Z. G. Xia; Y. Chen; Q. S. Chen; Y. Chen; X. Y. Zeng; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 161 KB

Dose-dense rituximab-CHOP compared with

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial

✍ Delarue, Richard; Tilly, Hervé; Mounier, Nicolas; Petrella, Tony; Salles, Gilles 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 354 KB

Cost-Effectiveness Analysis of the Addit

Cost-Effectiveness Analysis of the Addition of Rituximab to CHOP in Young Patients with Good-Prognosis Diffuse Large-B-Cell Lymphoma

✍ Felicetto Ferrara, Dr Roberto Ravasio 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB